Copyright
©2014 Baishideng Publishing Group Inc.
World J Clin Urol. Nov 24, 2014; 3(3): 364-369
Published online Nov 24, 2014. doi: 10.5410/wjcu.v3.i3.364
Published online Nov 24, 2014. doi: 10.5410/wjcu.v3.i3.364
Ref. | Outcome | Oxford Centre for Evidence-Based |
Medicine 2011 Levels of Evidence | ||
Gelbard et al[22] | Improvement seen in 20 patients (4 had plaque disappearance, 16 had curvature decrease by 20%-100%) | 2 |
Gelbard et al[23] | Overall, 36% responsed to treatment. Improvement greatest in patients with lesser degree of pre-treatment curvature | 2 |
Jordan[24] | Significant mean changes from baseline angular deviation and plaque width at 3, 6, and 9 mo | 2 |
Gelbard et al[25] | Improved penile curvature (29.7% vs 11.0%, P < 0.05 ) and patient reported bother scores for treatment group vs placebo | 1 |
Gelbard et al[26] | Improved penile curvature (34% vs 18%, P < 0.0001) and patient reported symtom bother score for treatment group vs placebo | 1 |
- Citation: Marchalik D, Wright H, Hill F, Vora A. Use of intralesional collagenase in the treatment of peyronie’s disease: A review. World J Clin Urol 2014; 3(3): 364-369
- URL: https://www.wjgnet.com/2219-2816/full/v3/i3/364.htm
- DOI: https://dx.doi.org/10.5410/wjcu.v3.i3.364